chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got my fist dose primary vaccine, but it looks like the second dose is not available anywhere; but it looks like the second dose is not available anywhere.; no adverse event; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (I got my fist dose primary vaccine, but it looks like the second dose is not available anywhere), PRODUCT AVAILABILITY ISSUE (but it looks like the second dose is not available anywhere.) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    In December 2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (I got my fist dose primary vaccine, but it looks like the second dose is not available anywhere), PRODUCT AVAILABILITY ISSUE (but it looks like the second dose is not available anywhere.) and NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (I got my fist dose primary vaccine, but it looks like the second dose is not available anywhere), PRODUCT AVAILABILITY ISSUE (but it looks like the second dose is not available anywhere.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for PRODUCT ADMINISTRATION INTERRUPTED (I got my fist dose primary vaccine, but it looks like the second dose is not available anywhere) and PRODUCT AVAILABILITY ISSUE (but it looks like the second dose is not available anywhere.).    No concomitant medication were reported. No treatment information was provided by the reporter.   Reporter did not allow further contact
He got the vaccine, initially it seemed pretty expected.  About bedtime he started to feel a little different, like maybe his lymph nodes were responding a little bit in his jaw line.  Feeling like sensitivity or soreness, and that was kind of expected.  Then he went to bed and he started to feel like maybe a sore throat that was minor.  He went to bed and woke up the next day he started to notice that his cognitive ability was falling apart.  He is normally really sharp and quick, and later that day he was having trying to figure out how to put together a sentence.  He was able to think what he wanted to say, but not able to turn it into speech.  About 7:00 PM the next day at it's peak and not able to communicate anymore.  He told his fiance that he was having a lot of problems, and not able to talk very well and just rested.  Was scared and nervous, wanting to know if it was going to be permanent and not able to speak anymore.  He was able to communicate a little bit, but would take a full minute to be able to figure out how to get a single word out and to respond when he was being asked a question.   He then started using head jestures instead of talking.  He went to bed and then the following day his speech had come back a little bit and felt better about that.  He could communicate better, but not up to normal and went on for about 4-5 days after the shot, and slowing getting back to an area to being somewhat normal again.  Now he is able to speak pretty quickly, but it was a scary situation, and it was brain related which was the worse part of it.  He went to the place where he got the vaccine, and asked them what h e needed to do, and told them that he had a very weird reaction that he had not heard of before and did not know what to do and gave him our #.   He now feels that he is fully recovered.     He did not get the 2nd vaccine.
Sweats; Chills; Fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (Sweats), CHILLS (Chills) and FATIGUE (Fatigue) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HYPERHIDROSIS (Sweats), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, HYPERHIDROSIS (Sweats), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided Treatment Severe cold Tylenol
Patient was scheduled for dose two of Pfizer Covid-19 vaccine today 8/4/21. Upon review of the immunization Registry, I found he received dose one of Pfizer Covid-19 vaccine on 7/14/21 and also a dose of Moderna Covid-19 vaccine on 3/8/21 at another Pharmacy.
Developed repeated episodes of vomiting after receiving rabies vaccine and immunoglobulin injection.  Next day no energy, sore throat, no chills, no fever.
Minimum interval between vaccines or vaccine doses not followed - second dose administered 14 days after first.
Left side of neck had pain when moving neck for 1.5 days.  Sat. eve 23 Jan. I had a temperature of 100. degrees and felt punky.   Sunday morning temperature normal and neck felt better.
Patient developed double vision beginning 5-6 weeks after the booster; diagnosed as isolated Trochlear nerve (Cranial nerve IV) palsy.  Symptoms persistent 1 year later.  All labs and imaging normal.  Evaluated and confirmed by general ophthalmologist, neurologist, neuro-ophthamologist, ENT.
Case number PHEH2013US010965 is an initial spontaneous report received from a pharmacist on 15 may 2013: This report refers to an 18-year old male patient. He was given only MenCYW liquid conjugate component of MENVEO (batch number: X11078) intramuscularly on 13 may 2013. No adverse event was reported following this administration error (inappropriate preparation of medication).
REACTION TO COVID VACCINE; This spontaneous report received from a patient concerned a 45 year old female of unspecified race and ethnicity. The patient's weight was 88.2 kilograms, and height was not reported. The patient's concurrent conditions included primary pulmonary hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown, expiry: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. The patient received epoprostenol sodium (form of admin unknown, intravenous, batch number: MM248M0101 expiry: 30-JUN-2022) 1.5 mg, frequency, and therapy dates were not reported for drug used for unknown indication. Concomitant medications included macitentan and warfarin for drug used for unknown indication.  On an unspecified date, the patient experienced reaction to covid vaccine, and was hospitalized on 07-MAY-2021. On an unspecified date, the patient died from reaction to covid vaccine. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and dose of epoprostenol sodium was not changed. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0. 20210521894-COVID-19 VACCINE AD26.COV2.S-REACTION TO COVID VACCINE. This event(s) is considered not related. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: REACTION TO COVID VACCINE
Unlike my first two doses, where I experienced fever and strong symptoms for a couple of days and then felt healthy, my fever lasted for several days (returning after I took an Aleve one night to sleep) and I did not feel well until the following Friday or really even Saturday. I still experience minor throat irritation and phlegm today (Saturday). The most concerning symptom was a pounding heart in the middle of the night, multiple nights (2-3 nights), at a level that I could not sleep. I woke my partner up crying the first time because I was scared and had never felt my heart "thunk" in that way. I am wondering if the beating could also have been exacerbated by taking a hot bath before bed. I also experienced sharp, sudden headaches that were distinct from other, more normal headaches throughout this time. Mostly the sharp pain happened on the right side of my head, although one time I felt it on the left side. These types of headaches are foreign to me and disturbing. Since Friday I have not had these extreme symptoms. Still, I feel concerned about my heart and am more conscious of it now, so it's hard to say if it is beating truly normally again. I am sleeping more deeply now that the fever has broken so might not notice irregularities as much.
A hot bump; Itchiness / itchy bump; Redness / a red bump; Pain; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (A hot bump), VACCINATION SITE PRURITUS (Itchiness / itchy bump), VACCINATION SITE ERYTHEMA (Redness / a red bump), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness / itchy bump), VACCINATION SITE ERYTHEMA (Redness / a red bump), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling). On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (A hot bump). On 23-Jan-2021, VACCINATION SITE PRURITUS (Itchiness / itchy bump), VACCINATION SITE ERYTHEMA (Redness / a red bump), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) had resolved. At the time of the report, VACCINATION SITE WARMTH (A hot bump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment was provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Are going to receive the second dose of Shingrix at a longer interval; The case will be considered as invalid as the patient are going to receive the second dose of Shingrix at a longer interval' hence it seems enquiry and potential medication error and reason for this delay not specified if it was due to current pandemic.
Horrible inflammation; Severe pain; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Horrible inflammation) and PAIN (Severe pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Gouty arthritis, Osteoarthritis, Baker's cyst and Chondrocalcinosis.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (Horrible inflammation) and PAIN (Severe pain). The patient was treated with PREDNISONE for Osteoarthritis flare up, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, INFLAMMATION (Horrible inflammation) and PAIN (Severe pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, C-reactive protein: high (High) High c-reactive protein in blood..    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No concomitant medications were reported. Patient stated that she received Cortisone injection in the knee on 01-Feb-2021. Patient had severe swollen right leg due to Osteoarthritis Flare-up on an unknown date. She stated that she had this problem in Oct, Nov and Dec of 2020.She also reported that she took second dose of Moderna vaccine on an unknown date. Patient stated that swelling was due to osteoarthritis and pseudogout  and not due to Moderna vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Added patient demographics (age and DOB). New events swollen legs and severe pain with event outcome as unknown. The treatment drug Tylenol was added. On 18-May-2021: Added patient medical history information as reported. Patient took second dose with very limited information was added. On 22-Jul-2021: The event Swollen legs removed.
Erythematous skin rash at injection site onset about 9 days after injection Swollen axillary lymph node in left axilla, onset about 7 days after injection
Yeast infection after first dose; This spontaneous case was reported by a consumer and describes the occurrence of FUNGAL INFECTION (Yeast infection after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced FUNGAL INFECTION (Yeast infection after first dose). At the time of the report, FUNGAL INFECTION (Yeast infection after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Information has been received from a licensed practical nurse concerning an 8 week old female with no pre-existing medical history of allergies who on 27-NOV-2007 at 11:00 and on 29-JAN-2008 at 14:15 was vaccinated PO with her first and second doses of Rotateq (lot# 657671/0902U, 657986/1205U).  There was no illness at the time of vaccination.  On 27-NOV-2007 beginning the same day of the first vaccination, the patient experienced severe diarrhea, vomiting and rash.  The patient did not seek medical attention.  No labs or diagnostic tests were performed.  Subsequently the patient recovered (date unknown).  On 29-JAN-2008 beginning the same day of the second vaccination, the patient experienced severe diarrhea, vomiting and rash.  Subsequently, the patient recovered (date unknown).  There was no product quality complaint.  Additional information has been requested.
Rash on both lower extremities, left greater than right, that appeared as hives. Patient was offered IM BENADRYL (no PO BENADRYL was available in clinic) and parents declined. He was observed in clinic for 30 minutes with almost clear resolution of rash (hives improved, erythema of lower extremities remained). Parents were instructed to give PO BENADRYL at home and monitor for further signs of reaction.
Within 24 hours of receiving the Tdap vaccine patient had first ever seizure resulting in hospitalization for 4 days.
This spontaneous report as received from a consumer via Clinic refers to a currently 14 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-AUG-2017, the patient was vaccinated with improperly stored dose of M-M-R II, recombinant human albumin (rHA) 1 dose unit (lot # M020073, Expiry date was not reported)) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1801USA000166:
Looking back the initial onset date was 09/20/10 as ITP could be seen near her left elbow. It wasn't until 10/01/10 that her pedi saw ITP in numerous areas and also blood leaking from ear, nose and mouth. On this date blood was drawn and platelets were less than 1,000 and was admitted to ICU.
Patient had a stroke at 4:30 in the morning after receiving his 1st Pfizer vaccine. He was taken to the ED and treated. He woke up with left side paralysis and slurred speech.  Symptoms nearly resolved after 4 days.
About 2 weeks after receiving the vaccine, patient noticed a rash at the site of injection that was itchy and warm to touch.  She applied an ice pack but no relief.
Information was received on 26-OCT-2015 from a pharmacist who reported that a patient (age and gender not specified) received the first dose of the series of an unspecified M-M-R II or PROQUAD (unspecified lot/expiration date and dosage) at 10 months old. The patient also received two additional vaccination doses of unspecified M-M-R II or PROQUAD (unspecified lot/expiration date or dosage) on unspecified dates. The patient is in the pharmacy seeking a fourth dose of M-M-R II for a school requirement on 26-OCT-2015. It was confirmed that a fourth dose of M-M-R II was not administered to the patient. No adverse effects were reported. No further information was provided. Additional information has been requested.
pt recvd vax & devel inc blood pressure of 180/130 w/ a pulse of 114 & n;
Information has been received from a male consumer who was vaccinated with a dose of Zostavax. The consumer stated, "The medication my doctor gave me for Shingles did not work." No further information available. Additional information has been requested.
His arm extremely sore; This is a spontaneous report from a contactable pharmacist. A adult male patient received bnt162b2 (PFIZER- BIONTECH COVID- 19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation in pharmacy or drug store. Medical history included covid-19 about a year ago and cardiac operation. Concomitant medications included allopurinol, amitriptyline, bumetanide, carvedilol, colchicine, diazepam, glimepiride, lisinopril, loratadine, meloxicam, metformin, methotrexate, metolazone, omeprazole, oxycodone, semaglutide (OZEMPIC), pregabalin, fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY), plecanatide (TRULANCE), ergocalciferol (VIT D), ursodiol and docusate sodium (STOOL SOFTENER). On an unspecified date, the patient's arm was extremely sore. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
This case was reported by a consumer and described the occurrence of irregular heartbeat in a 82-year-old female subject who was vaccinated with Influenza vaccine (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included arrhythmia and atrial defibrillation. In October 2007, the subject received a dose of Influenza vaccine (unknown, right arm). In 2007, 12 hours after vaccination with Influenza vaccine, the subject experienced irregular heartbeat. The subject reported that she was concerned about taking the flu shot this year because last year about 14 to 14 hours after receiving her flu shot, she experienced irregular heartbeat. She contacted her physician, who instructed her to contact emergency medical services (EMS). She was taken to the local emergency room where she reported no treatment was given, but the irregular heart beat resolved and she was sent home about two hours later. She was not sure what product she was given, but felt strongly it was a GSK product. The subject denied any medications or blood thinners with her current history of arrhythmia and atrial fibrillation. At the time of reporting the event was resolved.
INCHES LONG, NOT RAISED, WARM TO TOUCH, PINK IN COLOR, ABOUT 5 INCHES IN WIDTH, DENY ITCHING, LOCATION NOT AT THE INJECTION SITE (ISOLATED PINK PATCH FURTHER DOWN THE UPPER ARM).
Received vaccine on 10/19/21, developed leg weakness starting 10/26/21, was admitted to the hospital on 11/8/21 and spinal tap confirmed Guillain-Barré  Syndrome
Severe sinus infection and ear infection (had never had an ear infection in my life prior to this one); prescribed antibiotic and prednisone; after finishing all medication, one week later experienced extreme vertigo and nausea; prescribed a 5-day pack of prednisolone for this. Still have some fluid/pressure in my ears for which I am trying to use Mucinex to resolve.
Pins and Needles Feeling in Both Lips; Upper Body Itching All Over; This is a spontaneous report from a contactable Consumer or other non-health care professional (Patient).  An 85-years-old male patient received bnt162b2 (COMIRNATY PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection; (Batch no: not reported/Lot Number: EN6198) via an unspecified route of administration, administered in Arm Right on 03Mar2021 08:30 (at the age of 85 years) dose 1, single for covid-19 immunization at Hospital Main Building. Medical history and concomitant medications were not reported. Known allergies reported as he was severely allergic to all crustaceans, shrimp, crab, lobster and first time he had an anaphylactic reaction was when he was 16-years-old, also highly allergic to penicillin (was 20 years ago), cipro (was given once as prophylactic during a medical procedure of Colonoscopy and he reacted within 10 sec), sulfa drugs (he experienced that reaction while getting x rays) and allergic to grass, dust, pollen, perfume, and flowers. No Family Medical History Relevant to AE. No Additional Vaccines Administered on Same Date of the Pfizer Suspect. No prior vaccinations taken within 4 weeks. On 03Mar2021, Patient had the injection at 8:30 AM and the reaction started at 10:30 AM within two hours after the first injection, he experienced with reactions of pins and needles in both lips and his upper body was itching all over. He immediately took 50mg of Benadryl and a half an hour later his symptoms went away and he stated that he was not sure if the Benadryl stopped the reaction because it stopped quickly. AEs did not require to visit Emergency Room or Physician's office. No Investigation Assessment was provided. No relevant tests reported. Therapeutic measures included 50mg of Benadryl. Patient reported that he was scheduled for his second shot tomorrow and was very concerned about getting the next injection. The outcome of the events was recovered on 03Mar2021.   No follow-up attempts are possible. No further information is expected.
ON 4/9/2021, STARTED OUT WITH PAIN FROM  LEFT SIDE OF BUTTOCKS ALL THE WAY DOWN TO LEG. PAIN WHEN I MOVED AND LAYING DOWN. SLIGHT TOUCH TO MY LEFT SIDE WAS JUST PAINFUL. I WASN'T DOING ANYTHING THAT FIRST DAY, I HAD GOTTEN UP FROM THE COUCH AND FELT THE SHARP PAIN AND IT JUST GOT WORST THROUGH THE NIGHT.  NEXT DAY I WENT TO URGENT CARE, COULD HARDLY WALK OR SIT DUE TO PAIN. COUPLE DAYS LATER ON 4/13/2021 WENT TO ER DUE TO STILL ONGOING PAIN.
Patient reports that her arm is itchy and had raised red bumps around the injection site. No systemic reactions were reported.
Sore throat symptoms appeared about 8 hours after injection. Over 24 hours later at the time of this submission (4:12 PM on 12/17/2016) symptoms persist and are stronger. No other flu-like symptoms are present. The pain/soreness feels more like a physical injury than from a flu infection. Phlegm/mucus of some sort also appeared a day after injection but is subsiding fast. No treatment administered.
HAND ITCHING WITH RASH. MONDAY HAD HIVES ALL OVER BODY, SHORTNESS OF BREATH.